Cronos Group Inc. (CRON) vs Nektar Therapeutics (NKTR)

A side-by-side comparison of Cronos Group Inc. and Nektar Therapeutics across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRON vs NKTR

growth of $100 · dividends reinvested · last 10y
CRON +258.4% (+13.6%/yr)NKTR -83.4% (-16.4%/yr)CRON compounded faster over this window
Log scale — wide-divergence pair
1101001k10kStart $10020182020202220242026$358$17
CRON NKTR

CRON vs NKTR: by the numbers

  • •CRON is the larger company ($1.22B vs $1.18B market cap).
  • •CRON is profitable (30.98% net margin) while NKTR runs a net loss (-287.84%).
  • •CRON grew revenue faster over the past five years (31.80% vs -12.34% CAGR).

Metrics side by side

Valuation

MetricCRONNKTR
P/E ratio17.97N/A
P/S ratio5.4021.62
P/B ratio1.141.31
EV / EBITDA27.67N/A
FCF yield4.09%N/A

Profitability

MetricCRONNKTR
Gross margin36.16%99.36%
Operating margin-11.96%-240.38%
Net margin30.98%-287.84%
ROE6.53%-17.40%
ROIC1.12%-12.53%

Growth (annualized)

MetricCRONNKTR
Revenue CAGR (5Y)31.80%-12.34%
Total return CAGR (5Y)-9.92%-30.33%

Frequently asked

Which has grown faster, CRON or NKTR?
Over the past five years, CRON grew revenue faster — CRON at a 31.80% CAGR versus NKTR at -12.34%.
Is CRON or NKTR more profitable?
CRON runs the higher net margin — CRON at 30.98% versus NKTR at -287.84%.
How have CRON and NKTR total returns compared?
Over the past 10 years, CRON delivered 13.62% and NKTR delivered -16.49% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.